Tripterygium wilfordii multiglycoside-induced hepatotoxicity via inflammation and apoptosis in zebra

来源 :中国天然药物 | 被引量 : 0次 | 上传用户:lpdshr
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Tripterygium wilfordii multiglycoside(GTW)is a commonly used compound for the treatment of rheumatoid arthritis(RA)and immune diseases in clinical practice.However,it can induce liver injury and the mechanism of hepatotoxicity is still not clear.This study was designed to investigate GTW-induced hepatotoxicity in zebrafish larvae and explore the mechanism involved.The 72 hpf(hours post fertilization)zebrafish larvae were administered with different concentrations of GTW for three days and their mortality,malformation rate,morphological changes in the liver,transaminase levels,and histopathological changes in the liver of zebrafish larvae were detected.The reverse transcription-polymerase chain reaction(RT-PCR)was used to examine the levels of mi-croRNA-122(miR-122)and genes related to inflammation,apoptosis,cell proliferation and liver function.The results showed that GTW increased the mortality of zebrafish larvae,while significant malformations and liver damage occurred.The main manifestations were elevated levels of alanine aminotransferase(ALT)and aspartate aminotransferase(AST),significant liver atrophy,vacuoles in liver tissue,sparse cytoplasm,and unclear hepatocyte contours.RT-PCR results showed that the expression of miR-122 significantly decreased by GTW;the mRNA levels of inflammation-related genes il1β,il6,tnfα,il10,cox2 and ptges significantly increased;the mRNA level of tgfβ significantly decreased;the mRNA levels of apoptosis-related genes,caspase-8 and caspase-9,significantly in-creased;the mRNA level of bcl2 significantly decreased;the mRNA levels of cell proliferation-related genes,top2α and uhrfl,signi-ficantly reduced;the mRNA levels of liver function-related genes,alr and cyp3cl,significantly increased;and the mRNA level of cyp3a65 significantly decreased.In zebrafish,GTW can cause increased inflammation,enhanced apoptosis,decreased cell prolifera-tion,and abnormal expression of liver function-related genes,leading to abnormal liver structure and function and resulting in hepato-toxicity.
其他文献
目的 探讨α-硫辛酸(LA)通过激活腺苷酸活化蛋白激酶(AMPK)/哺乳动物雷帕霉素靶蛋白(mTOR)通路改善T2DM大鼠肾脏病变.方法 40只大鼠分为正常对照组(Con)、T2DM组、LA组、复合物C组(Comp C)和LA+Comp C组,每组各8只.检测各组大鼠FPG、24 h尿蛋白水平,计算肾脏肥大指数,光镜和电镜观察大鼠肾脏病理变化,Weatern blot检测大鼠肾脏相关蛋白表达水平.结果 与NC组比较,T2DM组FPG、肾脏肥大指数、24 h尿蛋白升高(P<0.01),光镜和电镜下均可见肾脏
DKD是DM常见微血管并发症,由于长期高血糖及高胰岛素血症,机体处于血栓前状态,易伴发肾小球微血栓(GMT)形成.炎症信号通路和炎症因子参与GMT形成,引起微循环障碍,加速肾小球硬化,加重肾脏损伤.本文对DKD引起的GMT与炎症相关性研究进展进行综述.
动态血糖监测(CGM)技术迅速发展,已成为DM管理的重要方法.规范合理应用CGM系统可明显降低DM患者HbA1c水平,减少血糖波动及低血糖风险,提高血糖控制效果和生活质量,对改善DM患者预后意义重大.本文对CGM技术与临床研究进展进行综述.
中南大学湘雅二医院国家代谢性疾病临床医学研究中心、中国民族卫生协会、《糖尿病天地》杂志社共同主办的“第十六届湘雅国际糖尿病免疫学论坛”(以下简称“论坛”)于2021年4月23~25日在湖南长沙举行.
期刊
一、Ins治疗现状及挑战rn中国DM患者负担沉重,约占全球DM患者的1/4[1].尽管DM防控工作取得一定进步,但我国仍有50. 6%的T2DM患者未能实现良好的血糖控制[2].DM作为一种进展性疾病[3],起始Ins治疗是疾病管理的必经阶段[4].基础胰岛素方案是国内外指南[5-6]共同推荐的Ins起始方案,且一旦起始基础胰岛素治疗,为实现良好的血糖控制,对Ins剂量的合理调整十分必要.
期刊
Physalin B(PB),one of the major active steroidal constituents of Solanaceae Physalis plants,has a wide variety of bio-logical activities.We found that PB significantly down-regulated β-amyloid(Aβ)secretion in N2a/APPsw cells.However,the underly-ing mechan
During the pathogensis of rheumatoid arthritis(RA),activated RA fibroblast-like synoviocytes(RA-FLSs)combines similar proliferative features as tumor and inflammatory features as osteoarthritis,which eventually leads to joint erosion.Therefore,it is imper
Ocotillol(OT)-type ginsenosides,one subtype of ginsenosides,consist of a dammarane skeleton and a tetrahydrofuiran ring.Most naturally-occurring OT-type ginsenosides exist in Panax species,particularly in Panax quinquefolius,which may be attrib-uted to th
Sargassum fusiforme(S.fusiforme)has been used as an ingredient in Chinese herbal medicine for thousands of years.However,there are a limited number of studies concerning its therapeutic mechanism.High performance gel permeation chromato-graphy(HPGPC)analy
Berberis amurensis(Berberidaceae)is a traditional Chinese medicine,which is often used to treat hypertension,in-flammation,dysentery and enteritis.It contains alkaloids,mainly including berberine,berbamine,magnoflorine,jatrorrhizine and pal-matine.Berberi